IRIS Guide for Applicants - Updated Submission Requirements
MAHs and sponsors must register for an EMA account and appropriate role to submit via the IRIS platform, as this is a new requirement for all IRIS submissions.
Tag archive
MAHs and sponsors must register for an EMA account and appropriate role to submit via the IRIS platform, as this is a new requirement for all IRIS submissions.
Organizations must establish an active EMA user account, ensure they have a valid EMA customer account number, and complete the SPOR/OMS registration process within five to ten working days if not previously registered.
Ensure all relevant teams are prepared to transition to the mandatory SEND format for data submissions by the effective date of 15 June 2026.
Review and update data submission practices to align with the new technical specifications; ensure compliance with FDA-supported data standards.
Clinical trial sponsors must update internal standard operating procedures (SOPs), conduct staff training on the functionality of the new ASR module, and utilize the CTIS training environment to ensure readiness for compliance with the new workflow.
MAHs and technical teams must review the revised API registration requirements and implement necessary system updates to comply by the established timelines.
Subscribe to impact-first pharmacovigilance updates. Select every role you want in your digest.
Digest roles: Regulatory Intelligence Lead. Work email only